Anteris Technologies Ltd (AVR.AX)
AUD 9.04
(5.24%)
AUD 9.04
(5.24%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 17.03 Million AUD | 66.05% |
| 2022 | 10.26 Million AUD | -32.19% |
| 2021 | 15.13 Million AUD | 47.73% |
| 2020 | 10.24 Million AUD | -2.15% |
| 2019 | 10.46 Million AUD | 0.85% |
| 2018 | 10.38 Million AUD | -11.57% |
| 2017 | 11.73 Million AUD | 154.76% |
| 2016 | 4.6 Million AUD | 11.31% |
| 2015 | 4.13 Million AUD | 53.21% |
| 2014 | 2.7 Million AUD | 4.14% |
| 2013 | 2.59 Million AUD | 74.28% |
| 2012 | 1.48 Million AUD | 94.79% |
| 2011 | 764.25 Thousand AUD | -31.13% |
| 2010 | 1.1 Million AUD | 598.22% |
| 2009 | 158.93 Thousand AUD | -21.77% |
| 2008 | 203.17 Thousand AUD | 15.86% |
| 2007 | 175.36 Thousand AUD | -28.44% |
| 2006 | 245.05 Thousand AUD | -55.56% |
| 2005 | 551.37 Thousand AUD | 2451.36% |
| 2004 | 21.61 Thousand AUD | -61.06% |
| 2003 | 55.49 Thousand AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 21.82 Million AUD | 0.0% |
| 2023 FY | 17.03 Million AUD | 66.05% |
| 2023 Q2 | 12.29 Million AUD | 0.0% |
| 2023 Q4 | 17.03 Million AUD | 0.0% |
| 2022 Q2 | 11.92 Million AUD | 0.0% |
| 2022 Q4 | 10.26 Million AUD | 0.0% |
| 2022 FY | 10.26 Million AUD | -32.19% |
| 2021 FY | 15.13 Million AUD | 47.73% |
| 2021 Q2 | 14.02 Million AUD | 0.0% |
| 2021 Q4 | 15.13 Million AUD | 0.0% |
| 2020 FY | 10.24 Million AUD | -2.15% |
| 2020 Q2 | 8.27 Million AUD | 0.0% |
| 2020 Q4 | 10.24 Million AUD | 0.0% |
| 2019 Q4 | 10.46 Million AUD | 0.0% |
| 2019 FY | 10.46 Million AUD | 0.85% |
| 2019 Q2 | 9.3 Million AUD | 0.0% |
| 2018 Q2 | 11.74 Million AUD | 0.0% |
| 2018 FY | 10.38 Million AUD | -11.57% |
| 2018 Q4 | 10.38 Million AUD | 0.0% |
| 2017 FY | 11.73 Million AUD | 154.76% |
| 2017 Q2 | 4.6 Million AUD | 0.0% |
| 2016 Q4 | 1.66 Million AUD | 0.0% |
| 2016 Q2 | 4.13 Million AUD | 0.0% |
| 2016 FY | 4.6 Million AUD | 11.31% |
| 2015 FY | 4.13 Million AUD | 53.21% |
| 2015 Q4 | 2.89 Million AUD | 0.0% |
| 2015 Q2 | 2.7 Million AUD | 0.0% |
| 2014 Q2 | 2.59 Million AUD | 0.0% |
| 2014 Q4 | 3.19 Million AUD | 0.0% |
| 2014 FY | 2.7 Million AUD | 4.14% |
| 2013 FY | 2.59 Million AUD | 74.28% |
| 2013 Q4 | 826.82 Thousand AUD | 0.0% |
| 2013 Q2 | 1.48 Million AUD | 0.0% |
| 2012 FY | 1.48 Million AUD | 94.79% |
| 2012 Q4 | 500.31 Thousand AUD | 0.0% |
| 2012 Q2 | 764.25 Thousand AUD | 0.0% |
| 2011 FY | 764.25 Thousand AUD | -31.13% |
| 2011 Q2 | 1.1 Million AUD | 0.0% |
| 2010 FY | 1.1 Million AUD | 598.22% |
| 2010 Q2 | 158.93 Thousand AUD | 0.0% |
| 2009 FY | 158.93 Thousand AUD | -21.77% |
| 2009 Q2 | 203.17 Thousand AUD | 0.0% |
| 2008 FY | 203.17 Thousand AUD | 15.86% |
| 2008 Q2 | 175.36 Thousand AUD | 0.0% |
| 2007 FY | 175.36 Thousand AUD | -28.44% |
| 2007 Q2 | 245.05 Thousand AUD | 0.0% |
| 2006 FY | 245.05 Thousand AUD | -55.56% |
| 2006 Q2 | 551.37 Thousand AUD | 0.0% |
| 2005 FY | 551.37 Thousand AUD | 2451.36% |
| 2005 Q2 | 21.61 Thousand AUD | 0.0% |
| 2004 Q2 | 55.49 Thousand AUD | 0.0% |
| 2004 FY | 21.61 Thousand AUD | -61.06% |
| 2003 FY | 55.49 Thousand AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| 4DMedical Limited | 49.08 Million AUD | 65.289% |
| Adherium Limited | 3.4 Million AUD | -400.158% |
| Aroa Biosurgery Limited | 14.77 Million AUD | -15.296% |
| Atomo Diagnostics Limited | 1.29 Million AUD | -1216.382% |
| Control Bionics Limited | 2.75 Million AUD | -517.45% |
| CardieX Limited | 8.56 Million AUD | -99.002% |
| Compumedics Limited | 22.14 Million AUD | 23.067% |
| Cochlear Limited | 904.6 Million AUD | 98.116% |
| CleanSpace Holdings Limited | 6.94 Million AUD | -145.178% |
| Cyclopharm Limited | 13.65 Million AUD | -24.786% |
| EMVision Medical Devices Ltd | 5.45 Million AUD | -212.321% |
| Nova Eye Medical Limited | 8.55 Million AUD | -99.242% |
| HeraMED Limited | 1.5 Million AUD | -1031.465% |
| Imricor Medical Systems, Inc. | 25 Million AUD | 31.855% |
| ImpediMed Limited | 6.24 Million AUD | -172.932% |
| InhaleRx Limited | 911.41 Thousand AUD | -1769.532% |
| LBT Innovations Limited | 5.5 Million AUD | -209.353% |
| Micro-X Limited | 12.63 Million AUD | -34.868% |
| Neurotech International Limited | 314.69 Thousand AUD | -5314.431% |
| OncoSil Medical Limited | 1.98 Million AUD | -759.698% |
| PolyNovo Limited | 37.04 Million AUD | 54.002% |
| Respiri Limited | 3.55 Million AUD | -379.439% |
| SomnoMed Limited | 24.78 Million AUD | 31.24% |
| Universal Biosensors, Inc. | 10.61 Million AUD | -60.557% |
| Uscom Limited | 2.07 Million AUD | -721.729% |
| Visioneering Technologies, Inc. | 2.76 Million AUD | -515.819% |